Overview |
bs-7109R-Cy5.5 |
PARP4 Polyclonal Antibody, Cy5.5 Conjugated |
WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
Rat, Pig |
Human, Mouse, Sheep, Rabbit |
Specifications |
Cy5.5 |
Rabbit |
KLH conjugated synthetic peptide derived from human PARP4 |
851-950/1724 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
143 |
Cytoplasm, Nucleus |
PARP related / IalphaI related H5 / proline rich; Vault poly ADP ribose polymerase; VPARP; 193kDa vault protein; ADP ribosyltransferase NAD+ poly ADP ribose polymerase like 1; ADP ribosyltransferase like 1; ADPRT L1; ADPRTL 1; ADPRTL1; H5 proline rich; I alpha I related; KIAA0177; Minor vault p193 protein; p193 antibody PARP 4; PARP related; PARPL; PH 5P; PH5P; Poly ADP ribose polymerase 4; Poly ADP ribose polymerase family member 4; Poly ADP ribose synthetase; Poly ADP ribosyl transferase like 1; Poly ADP ribose polymerase 4; Poly ADP ribose polymerase family member 4; Vault 3; Vault; Vault poly ADP ribose polymerase; Vault protein 193 kDa; Vault3; PARP4_HUMAN. |
Component of the vault ribonucleoprotein particle which is at least composed of MVP, PARP4 and one or more vault RNAs (vRNAs). Binds to MVP. Associates with TEP1. Widely expressed; the highest levels are in the kidney; also detected in heart, placenta, lung, liver, skeletal muscle, spleen, leukocytes and pancreas. |
Application Dilution |
WB |
1:300-5000 |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |